Our recent publication “Therapeutic Evaluation of the Acinetobacter baumannii Phage Phab24 for Clinical Use”, published in Virus Research, highlights the characterization of Phab24, a bacteriophage that targets a colistin-resistant Acinetobacter baumannii strain. This work is a crucial step toward advancing phage therapy, including testing phage stability, infection dynamics, and genomic analysis.
A heartfelt thank you to Liwei Zhang for her hard work and dedication, and special thanks to the Loh Group at Fraunhofer IZI for this fruitful collaboration!
DOI: 10.1016/j.virusres.2022.198621
The Leptihn Lab 